(Q63434501)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

Impact of CD34 subsets on engraftment kinetics in allogeneic peripheral blood stem cell transplantation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

stem cell transplantation

5 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Douaa Sayed

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

N El-Sharkawy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

H K Mahmoud

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M-R Khalaf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

A El Haddad

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

O Fahmy

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

R Abd El Fattah

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

129-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15568034%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704755

5 January 2020

exact match

0 references

cites work

Engraftment of primates with G-CSF mobilized peripheral blood CD34+ progenitor cells expanded in G-CSF, SCF and MGDF decreases the duration and severity of neutropenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Increased blood volume and CD34(+)CD38(-) progenitor cell recovery using a novel umbilical cord blood collection system.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Peripheral blood vs bone marrow as a source for allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Peripheral blood stem cells for allogeneic transplantation: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Société Française de Greffe de Moelle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Allogeneic peripheral blood stem cell transplantation for haematological malignancies--an analysis of kinetics of engraftment and GVHD risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Effect of CD34+ peripheral blood progenitor cell dose on hematopoietic recovery

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Reduction of intra- and interlaboratory variation in CD34+ stem cell enumeration using stable test material, standard protocols and targeted training. DK34 Task Force of the European Working Group of Clinical Cell Analysis (EWGCCA).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Progenitor cell subsets and engraftment kinetics in children undergoing autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Technical aspects and clinical impact of hematopoietic progenitor subset quantification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Assays to determine hematopoietic stem cell content in blood or marrow grafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: an analysis of progenitor-cell quantity and quality and factors predicting for these parameters in 101 pretreated patients with malignant lymphom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Factors that influence collection and engraftment of autologous peripheral-blood stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021

Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704755

7 January 2021